A2A-ADENOSIN-REZEPTOR-ANTAGONISTEN

Patent europeic · EP2038285 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2038285
Numer da la dumonda
EP07796492
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-06-2007
Publitgà
25-03-2009
Concedì
17-02-2010
Stritgà
30-06-2011
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 487/04 (2006.01)
A61K 31/522 (2006.01)
A61P 25/16 (2006.01)
Prioritad
US 816516 P 26.06.2006
Dumonda PCT
PCT/US2007/014886 25.06.2007
Publicaziun PCT
WO2008/002596 03.01.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-01-2012

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.01.2012

  2. 17-02-2010

    Concedì

    Published in Swissreg on 17.02.2010

Partidas

Possessur

Schering Corporation

2000 Galloping Hill Road, Kenilworth, NJ 07033-0530, US

Inventur

CLASBY, Martin C.

Plainsboro, New Jersey 08536, US

CHACKALAMANNIL, Samuel

Califon, New Jersey 07830, US

STAMFORD, Andrew

Chatham Township, New Jersey 07928, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.